cisordinol depot 200 mg/ ml
orifarm as - zuklopentiksoldekanoat - injeksjonsvæske, oppløsning - 200 mg/ ml
cisordinol depot 200 mg/ ml
orifarm as - zuklopentiksoldekanoat - injeksjonsvæske, oppløsning - 200 mg/ ml
palonosetron fresenius kabi 250 mikrog
fresenius kabi norge as - palonosetronhydroklorid - injeksjonsvæske, oppløsning - 250 mikrog
fluanxol depot 100 mg/ ml
orifarm as - flupentiksoldekanoat - injeksjonsvæske, oppløsning - 100 mg/ ml
truxal 25 mg
orifarm as - klorprotiksenhydroklorid - tablett, filmdrasjert - 25 mg
levitra 20 mg
orifarm as - vardenafilhydroklorid - tablett, filmdrasjert - 20 mg
deltyba
otsuka novel products gmbh - delamanid - tuberkulose, multidrug-resistent - antimykobakterielle - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 og 5. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.
truxal 15 mg
h. lundbeck a/s - klorprotiksenhydroklorid - tablett, filmdrasjert - 15 mg
truxal 25 mg
h. lundbeck a/s - klorprotiksenhydroklorid - tablett, filmdrasjert - 25 mg
truxal 50 mg
h. lundbeck a/s - klorprotiksenhydroklorid - tablett, filmdrasjert - 50 mg